The 140 references in paper A. Zharikov Yu., Ya. Zverev F., V. Brukhanov M., V. Lampatov V., А. Жариков Ю., Я. Зверев Ф., В. Брюханов М., В. Лампатов В. (2009) “МЕХАНИЗМ ФОРМИРОВАНИЯ КРИСТАЛЛОВ ПРИ ОКСАЛАТНОМ НЕФРОЛИТИАЗЕ // MECHANISM OF FORMATION OF CRYSTALS IN OXALATE NEPHROLITHIASIS” / spz:neicon:nefr:y:2009:i:4:p:37-50

1
Ryall RL. The future of stone research: rummaging in the attic, Randall’s plaque, nanobacteria, and lessons from phylogeny. Urol Res 2008; 36(2): 77-97
(check this in PDF content)
2
Cooke SAR. The site of calcification in the human renal papilla. Br J Surg 1970; 57: 890-896
(check this in PDF content)
3
Haggit RC, Pitcock JA. Renal medullary calcifications: a light and electron microscopic study. J Urol 1971; 106: 342-347
(check this in PDF content)
4
Burry AF, Axelsen RA, Trolove P, Sallis JD. Calcification in the renal medulla: a classification based on a prospective study of 2261 necropsies. Hum Pathol 1976; 7: 435-449
(check this in PDF content)
5
Stoller ML, Shami GS, McCormick VD, Kerschmann RL. High resolution radiography of cadaveric kidneys: unraveling the mystery of Randall’s plaque formation. J Urol 1996; 156: 1263-1266
(check this in PDF content)
6
Kok DJ. Intratubular crystallization events. World J Urol 1997; 15 (4): 219-228
(check this in PDF content)
7
Брюханов ВМ, Зверев ЯФ, Лампатов ВВ и др. Функ­ ция почек в условиях экспериментального оксалатного не­ фролитиаза. Нефрология 2008; 12 (1): 69-74
(check this in PDF content)
8
Henle FGJ. On the anatomy of the kidney. Goettingen Nachrichten 1863: 125-135
(check this in PDF content)
9
Randall A. The origin and growth of renal calculi. Ann Surg 1937; 105 (6): 1009-1027
(check this in PDF content)
10
Randall A. The initiating lesions of renal calculus. Surg Gynecol Obstet 1937; 64: 201-208
(check this in PDF content)
11
Kok DJ. Crystallization and stone formation inside the nephron. Scanning Microsc 1996; 10: 471-485
(check this in PDF content)
12
Kok DJ, Schell-Feith EA. Risk factors for crystallization in the nephron: the role of renal development. J Am Soc Nephrol 1999; 10 (14): S364-S370
(check this in PDF content)
13
Khan SR, Thamilselvan S. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals. Mol Urol 2000; 4 (4): 305-312
(check this in PDF content)
14
Schepers MS, Duim RA, Asselman M et al. Internalization of calcium oxalate crystals by renal tubular cells: a nephron segment-specific process? Kidney Int 2003; 64 (2): 493-500
(check this in PDF content)
15
Bushinsky DA. Nephrolithiasis: site of the initial solid phase. J Clin Invest 2003; 111 (5): 602-605
(check this in PDF content)
16
Evan AP, Lingeman JE, Coe FL et al. Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 2003; 111: 607-616
(check this in PDF content)
17
Sepe V, Adamo G, La Fianza A et al. Henle loop basement membrane as initial site for Randall plaque formation. Am J Kidney Dis 2006; 48 (5): 706-711
(check this in PDF content)
18
Bulger RE, Trump BF. Fine structure of the rat renal papilla. Am J Anat 1966; 118: 685-696
(check this in PDF content)
19
Pitcock JA, Lyons H, Brown PS et al. Glycosaminoglycans of the rat renomedullary interstitium: ultrastructural and biochemical observations. Exp Mol Pathol 1988; 49 (3): 373-387
(check this in PDF content)
20
Вандер А. Физиология почки. Питер, СПб., 2000; 23-35
(check this in PDF content)
21
Asselman M, Verkoelen CF. Crystal-cell interaction in the pathogenesis of kidney stone disease. Curr Opin Urol 2002; 12: 271-276
(check this in PDF content)
22
Жариков АЮ, Брюханов ВМ, Зверев ЯФ, Лампатов ВВ. Современные представления о модуляторах оксалат­ ного нефролитиаза. I. Стимуляторы кристаллизации. Не­ фрология 2009; 13 (1): 56-72
(check this in PDF content)
23
Halperin ML, Kamel KS, Oh MS. Mechanisms to concentrate the urine: an opinion. Curr Opin Nephrol Hypertens 2008; 17 (4): 416-422
(check this in PDF content)
24
Asplin JR, Mandel NS, Coe FL. Evidence of calcium phosphate supersaturation in the loop of Henle. Am J Physiol 1996; 270 (4 Pt 2): F604-613
(check this in PDF content)
25
Hebert SC, Brown EM, Harris HW. Role of the Ca2+- sensing receptor in divalent mineral ion homeostasis. J Exp Biol 1997; 200: 295-302
(check this in PDF content)
26
Тиктинский ОЛ, Александров ВП. Мочекаменная бо­ лезнь. Питер, СПб., 2000; 53-67
(check this in PDF content)
27
Кадыров ЗА, Истратов ВГ, Сулейманов СИ. Некото­ рые вопросы этиологии и патогенеза мочекаменной болез­ ни. Урология 2006; 5: 98-101
(check this in PDF content)
28
Зверев ЯФ, Брюханов ВМ, Лампатов ВВ, Жариков АЮ. Современные представления о роли физико-химичес­ ких факторов в патогенезе кальциевого нефролитиаза. Не­ фрология 2009; 13 (1): 39-50
(check this in PDF content)
29
Verkoelen CF, Verhulst A. Proposed mechanisms in renal tubular crystal retention. Kidney Int 2007; 72: 13-18
(check this in PDF content)
30
Vermeulen CW, Lyon ES. Mechanisms of genesis and growth of calculi. Am J Med 1968; 45: 684-692
(check this in PDF content)
31
Finlayson B, Reid F. The expectation of free and fixed particles in urinary stone disease. Invest Urol 1978; 15: 442­ 448
(check this in PDF content)
32
Kok DJ, Khan SR. Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 1994; 46: 847-854
(check this in PDF content)
33
Evan AP. Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol 2009; DOI 10.1007/s00467-009-1116-y
(check this in PDF content)
34
Randall A. Papillary pathology as a precursor of primary renal calculus. J Urol 1940; 44: 580-589
(check this in PDF content)
35
Randall A. The etiology of primary renal calculus. Int Abstr Surg 1940; 71: 209-240
(check this in PDF content)
36
Prien EL. The riddle of Randall’s plaques. J Urol 1975; 114: 500-507
(check this in PDF content)
37
Verkoelen CF. Crystal retention in renal stone disease: a crucial role for glycosaminoglycan hyaluronan? J Am Soc Nephrol 2006; 17: 1673-1687
(check this in PDF content)
38
Anderson L, McDonald JR. The origin, frequency, and significance of microscopic calculi in the kidney. Surg Gynecol Obstet 1946; 82: 275-282
(check this in PDF content)
39
Carr RJ. A new theory on the formation of renal calculi. Br J Urol 1954; 26: 105-117
(check this in PDF content)
40
Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest 2005; 115 (10): 2598-2608
(check this in PDF content)
41
Evan AP, Coe FL, Lingeman JE, Worcester E. Insights on the pathology of kidney stone formation. Urol Res 2005; 33 (5): 383-389
(check this in PDF content)
42
Evan AP, Coe FL, Rittling SR. et al. Apatite plaque particles in inner medulla of kidneys of CaOx stone formers: osteopontin localization. Kidney Int 2005; 68: 145-154
(check this in PDF content)
43
Worcester E, Evan A, Bledsoe S et al. Pathophysiological correlates of two unique renal tubule lesions in rats with intestinal resection. Am J Physiol Renal Physiol 2006; 291 (5): F1061- 1069
(check this in PDF content)
44
Evan AP, Coe FL, Lingeman JE et al. Mechanism of formation of human calcium oxalate renal stones on Randall’s plaque. Anat Rec (Hoboken) 2007; 290 (10): 1315-1323
(check this in PDF content)
45
Evan AP, Lingeman JE, Coe FL, Worcester EM. Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone. Semin Nephrol 2008; 28 (2): 111-119
(check this in PDF content)
46
Wendt-Nordahl G, Evan AP, Spahn M, Knoll T Calcium oxalate stone formation. New pathogenetic aspects of an old disease. Urologe A 2008; 47 (5): 538, 540-544
(check this in PDF content)
47
Miller NL, Gillen DL, Williams JC Jr et al. A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall’s plaque. BJU Int 2009; 103 (7): 966-971
(check this in PDF content)
48
Baumann JM, Affolter B, Caprez U et al. Hydroxyapatite induction and secondary aggregation of calcium oxalate, two important processes in calcium stone formation. Urol Res 2001; 29 (6): 417-422
(check this in PDF content)
49
Matlaga BR, Williams JC, Kim SC et al. Endoscopic evidence of calculus attachment to Randall’s plaque. J Urol 2006; 175: 1720-1724
(check this in PDF content)
50
Pak CY. Nephrolithiasis. Curr Ther Endo Metab 1997; 6: 572-576
(check this in PDF content)
51
Bushinsky DA. Nephrolithiasis. J Am Soc Nephrol 1998; 9: 917-924
(check this in PDF content)
52
Bushinsky DA. Renal lithiasis. In: Humes HD, ed. Kelly’s Textbook of Medicine, New York, 2000; 1243-1248
(check this in PDF content)
53
Monk RD, Bushinsky DA. Nephrolithiasis and nephrocalcinosis. In: Johnson R, Frehally J, eds. Comprehensive Clinical Nephrology, London, 2000; 973-989
(check this in PDF content)
54
Monk RD, Bushinsky DA. Kidney stones. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, eds. Williams Textbook of Endocrinology, 10th ed., Philadelphia WBSaunders, 2003; 1411-1425
(check this in PDF content)
55
Coe FL, Parks JH. Pathogenesis and treatment of nephrolithiasis. In: Seldin D, Giebisch G, eds. The kidney, Philadelphia, 2000; 1841-1867
(check this in PDF content)
56
Frick KK, Bushinsky DA. Molecular mechanisms of primary hypercalciuria. J Am Soc Nephrol 2003; 14: 1082-1095
(check this in PDF content)
57
Lemann J Jr, Lennon EJ, Piering WF et al. Evidence that glucose ingestion inhibits net renal tubular reabsorption of calcium and magnesium in man. J Lab Clin Med 1970; 75: 578-585
(check this in PDF content)
58
Breslau NA, Sakhaee K, Pak CY. Impaired adaptation to salt-induced urinary calcium losses in postmenopausal osteoporosis. Trans Assoc Am Physicians 1985; 98:107-115
(check this in PDF content)
59
Hess B, Ackermann D, Essig M et al. Renal mass and serum calcitriol in male idiopathic calcium renal stone formers: role of protein intake. J Clin Endocrinol Metab 1995; 80: 1916­ 1921
(check this in PDF content)
60
Favus MJ, Karnauskas AJ, Parks JH, Coe FL. Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J Clin Endocrinol Metab 2004; 89: 4937-4943
(check this in PDF content)
61
Pearce SH. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 1996; 335: 1115-1122
(check this in PDF content)
62
Thakker RV. Pathogenesis of Dent’s disease and related syndromes of X-linked nephrolithiasis. Kidney Int 2000; 57: 787­ 793
(check this in PDF content)
63
Weber S. Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis maps to chromosome 3q27 and is associated with mutations in the PCLN-1 gene. Eur J Hum Genet 2000; 8: 414-422
(check this in PDF content)
64
Брюханов ВМ, Зверев ЯФ. Побочные эффекты со­ временных диуретиков. Церис, Новосибирск, 2003; 12-30
(check this in PDF content)
65
Naesens M, Steels P, Verberckmoes R et al. Bartter’s and Gitelman’s syndromes: from gene to clinic. Nephron Physiol 2004; 96: 65-78
(check this in PDF content)
66
Heller HJ, Pak CYC. Primary hyperparathyroidism. In: Coe FL, Favus MJ, eds. Disorders of bone and mineral metabolism, Philadelphia, 2002; 516-534
(check this in PDF content)
67
Levi M, Bruesegem S. Renal phosphate-transporter regulatory proteins and nephrolithiasis. N Engl J 2008; 359: 1170-1173
(check this in PDF content)
68
Prie D, Ravery V, Boccon-Gibod L, Friedlander G. Frequency of renal phosphate leak among patients with calcium nephrolithiasis. Kidney Int 2001; 60: 272-276
(check this in PDF content)
69
Prie D, Huart V, Bakouh N et al. Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2 sodium-phosphate cotransporter. N Engl J Med 2002; 347: 983-991
(check this in PDF content)
70
Lapointe JY, Tessier J, Paquette Y et al. NPT2a gene variation in calcium nephrolithiasis with renal phosphate leak. Kidney Int 2006; 69: 2261-2267
(check this in PDF content)
71
Iwaki T, Sandoval-Cooper MJ, Tenehouse HS, Castellino FJ. A missense mutation in the sodium phosphate co­ transporter Slc34a1 impairs phosphate homeostasis. J Am Soc Nephrol 2008; 19 (9): 1753-1762
(check this in PDF content)
72
Juareguiberry G, Carpenter TO, Forman S et al. A novel missense mutation in SLC34A3 that causes hereditary hypophosphatemic rickets with hypercalciuria in humans identifies threonine 137 as an important determinant of sodium- phosphate cotransport in NaPi-IIc. Am J Physiol Renal Physiol 2008; 295: F371-F379
(check this in PDF content)
73
Karim Z, Gerard B, Bakouh N et al. Human NHERF1 mutations and responsiveness of the renal parathyroid hormone. N Engl J Med 2008; 359: 1128-1135
(check this in PDF content)
74
Hernando N, Gisler SM, Pribanic S et al. NaPi-IIa and interacting partners. J Physiol 2005; 567: 21-26
(check this in PDF content)
75
Khundmiri SJ, Ahmad A, Bennett RE et al. Novel regulatory function for NHERF-1 in Npt2a transcription. Am J Physiol Renal Physiol 2008; 294: F840-F849
(check this in PDF content)
76
Villa-Bellosta R, Barac-Nieto M, Breusegem SY et al. Interactions of the growth-related, type IIcrenal sodium/ phosphate cotransporter with PDZ proteins. Kidney Int 2008; 73: 456-464
(check this in PDF content)
77
Вощула ВИ. Мочекаменная болезнь: этиотропное и патогенетическое лечение, профилактика. ВЭВЭР, Минск, 2006; 107-110
(check this in PDF content)
78
Danpure CJ, Rumsby G. Molecular aetiology of primary hyperoxaluria and its implications for clinical management. Expert Rev Mol Med 2004; 2004: 1-16
(check this in PDF content)
79
Poore RE, Hurst CH, Assimos DG, Holmes RP. Pathways of hepatic oxalate synthesis and their regulation. Am J Physiol 1997; 272 (1): 289-294
(check this in PDF content)
80
Baker PR, Cramer SD, Kennedy M et al. Glycolate and glyoxylate metabolism in HepG2 cells. Am J Physiol Cell Physiol 2004; 287 (5): C1359-1365
(check this in PDF content)
81
Gambardella RL, Richardson KE. The pathways of oxalate formation from phenylalanine, tyrosine, tryptophan and ascorbic acid in the rat. Biochim Biophys Acta 1977; 499 (1): 156-168
(check this in PDF content)
82
Hatch M, Freel RW. The roles and mechanisms of intestinal oxalate transport in oxalate homeostasis. Semin Nephrol 2008; 28 (2): 143-151
(check this in PDF content)
83
Siva S, Barrack ER, Reddy GP et al. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease. BJU Int 2009; 103 (1):18-21
(check this in PDF content)
84
Sakhaee K. Recent advances in the pathophysiology of nephrolithiasis. Kidney Int 2009; 75 (6): 585-595
(check this in PDF content)
85
Soleimani M, The role of SLC26A6-mediated chloride/ oxalate exchange in causing susceptibility to nephrolithiasis. J Physiol 2008; 586 (5): 1205-1206
(check this in PDF content)
86
Jennings ML, Adame MF. Characterization of oxalate transport by the human erythrocyte band 3 protein. J Gen Physiol 1996; 107 (1):145-159
(check this in PDF content)
87
Baggio B, Gambaro G, Marchini F et al. Raised transmembrane oxalate flux in red blood cells in idiopathic calcium oxalate nephrolithiasis. Lancet 1984; 2 (8393): 12-13
(check this in PDF content)
88
Gambaro G, Marchini F, Piccoli A et al. The abnormal red-cell oxalate transport is a risk factor for idiopathic calcium nephrolithiasis: a prospective study. J Am Soc Nephrol 1996; 7 (4): 608-612
(check this in PDF content)
89
Varalakshmi P, Richardson KE. The effects of vitamin B-6 deficiency and hepatectomy on the synthesis of oxalate from glycolate in the rat. Biochim Biophys Acta 1983; 757 (1): 1-7
(check this in PDF content)
90
Nishijima S, Sugaya K, Morozumi M et al. Hepatic alanine-glyoxylate aminotransferase activity and oxalate metabolism in vitamin B6 deficient rats. J Urol 2003; 169 (2): 683-686
(check this in PDF content)
91
Thamilselvan S, Hackett RL, Khan SR. Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. J Urol 1997; 157 (3): 1059-1063
(check this in PDF content)
92
Thamilselvan S, Khan SR. Oxalate and calcium oxalate crystals are injurious to renal epithelial cells: results of in vivo and in vitro studies. J Nephrol 1998; 11 (1): 66-69
(check this in PDF content)
93
Khan SR, Thamilselvan S. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals. Mol Urol 2000; 4 (4): 305-312
(check this in PDF content)
94
Khan SR. Crystal-induced inflammation of the kidneys: results from human studies, animal models and tissue-culture studies. Clin Exp Nephrol 2004; 8 (2): 75-88
(check this in PDF content)
95
Selvan R. Calcium oxalate stone disease: role of lipid peroxidation and antioxidants. Urol Res 2002; 30 (1): 35-47
(check this in PDF content)
96
Thamilselvan S, Khan SR, Menon M. Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 2003; 31 (1): 3-9
(check this in PDF content)
97
Rashed T, Menon M, Thamilselvan S. Molecular mechanism of oxalate-induced free radical production and glutathione redox imbalance in renal epithelial cells: effect of antioxidants. Am J Nephrol 2004; 24 (5): 557-568
(check this in PDF content)
98
Зверев ЯФ, Брюханов ВМ, Талалаева ОС и др. О роли процессов свободно-радикального окисления в раз­ витии экспериментального нефролитиаза. Нефрология 2008; 12 (1): 58-63
(check this in PDF content)
99
Evan AP, Bledsoe SB, Smith SB, Bushinsky DA. Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats. Kidney Int 2004; 65 (1): 154-161
(check this in PDF content)
100
Green ML, Freel RW, Hatch M. Lipid peroxidation is not the underlying cause of renal injury in hyperoxaluric rats. Kidney Int 2005; 68: 2629-2638
(check this in PDF content)
101
Schepers MS, van Ballegooijen ES, Bangma CH, Verkoelen CF. Crystal cause acute necrotic cell death in renal proximal tubule cells but not in collecting tubule cells. Kidney Int 2005; 68 (4): 1543-1553
(check this in PDF content)
102
Schepers MS, van Ballegooijen ES, Bangma CH, Verkoelen CF. Oxalate is toxic to renal tubular cells only at supraphysiologic concentrations. Kidney Int 2005; 68 (4): 1660­ 1669
(check this in PDF content)
103
Verkoelen CF, Schepers MS, van Ballegooijen ES, Bangma CH. Effects of luminal oxalate or calcium oxalate on renal tubular cells in culture. Urol Res 2005; 33 (5): 321-328
(check this in PDF content)
104
Evan AP, Coe FL, Gillen D et al. Renal intraluminal crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec 2008; 291: 325-334
(check this in PDF content)
105
Umekawa T, Chegini N, Khan SR. Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells. Kidney Int 2002; 61 (1): 105-112
(check this in PDF content)
106
Gambaro G, D’Angelo A, Fabris A et al. Crystals, Randall’s plaques and renal stones: Do bone and atherosclerosis teach us something? J Nephrol 2004; 17 (6): 774-777
(check this in PDF content)
107
Evan AP, Lingeman JE, Coe FL, Worcester E. Randall’s plaque: pathogenesis and role calcium oxalate nephrolithiasis. Kidney Int 2006; 69: 1313-1318
(check this in PDF content)
108
Khan SR. Randall’s plaque and renal injury. Kidney Int 2007; 71: 83
(check this in PDF content)
109
Evan AP, Coe F, Lingeman JE. Response to «Randall’s plaque and renal injury». Kidney Int 2007; 71: 83-84
(check this in PDF content)
110
Escobar C, Byer KJ, Khaskheli H, Khan SR. Apatite induced renal epithelial injury: insight in to the pathogenesis of kidney stones. J Urol 2008; 180 (1): 379-387
(check this in PDF content)
111
Kohjimoto Y, Kennington L, Scheid CR, Honeyman TW. Role of phospholipase A2 in the cytotoxic effects of oxalate in cultured renal epithelial cells. Kidney Int 1999; 56 (4): 1432-1441
(check this in PDF content)
112
Scheid C, Honeyman T, Kohjimoto Y et al. Oxalate- induced changes in renal epithelial cell function: role in stone disease. Mol Urol 2000; 4 (4): 371-382
(check this in PDF content)
113
Scheid CR, Cao LC, Honeyman T, Jonassen JA. How elevated oxalate can promote kidney stone disease: changes at the surface and in the cytosol of renal cells that promote crystal adherence and growth. Front Biosci 2004; 9: 797-808
(check this in PDF content)
114
Ho JH, Lim MJ, Lee YJ. Oxalate inhibits renal proximal tubule cell proliferation via oxidative stress, p38 MAPK/JNK, and cPLA2 signaling pathways. Am J Physiol Cell Physiol 2004; 287: C1058-C1066
(check this in PDF content)
115
Jonassen JA, Cao LC, Honeyman T, Scheid CR. Mechanisms mediating oxalate-induced alterations in renal cell functions. Crit Rev Eukaryot Gene Expr 2003; 13 (1): 55-72
(check this in PDF content)
116
Cao LC, Honeyman TW, Cooney R et al. Mitochondrial dysfunction is a primary event in renal cell oxalate toxicity. Kidney Int 2004; 66 (5): 1890-1900
(check this in PDF content)
117
Jonassen JA, Cao LC, Honeyman T, Scheid CR. Intracellular events in the initiation of calcium oxalate stones. Nephron Exp Nephrol 2004; 98 (2): e61^ 64
(check this in PDF content)
118
Cao LC, Honeyman T, Jonassen J, Scheid C. Oxalate- induced ceramide accumulation in Madin-Darby canine kidney and LLC-PK1 cells. Kidney Int 2000; 57 (6): 2403-2411
(check this in PDF content)
119
Jonassen JA, Kohjimoto Y, Scheid CR, Schmidt M. Oxalate toxicity in renal cells. Urol Res 2005; 33 (5): 329-339
(check this in PDF content)
120
Baggio B, Gambaro G. Abnormal arachidonic acid content of membrane phospholipids—the unifying hypothesis for the genesis of hypercalciuria and hyperoxaluria in idiopathic calcium nephrolithiasis. Nephrol Dial Transplant 1999; 14 (3): 553-555
(check this in PDF content)
121
Cupisti A, Meola M, D’Alessandro C et al. Insulin resistance and low urinary citrate excretion in calcium stone formers. Biomed Pharmacother 2007; 61 (1): 86-90
(check this in PDF content)
122
Kajander EO, Kuronen I, Ekerman K et al. Nanobacteria from blood, the smallest culturable autonomously replicating agent on earth. Proc SPIE 1997; 3111: 420-428
(check this in PDF content)
123
Ciftcioglu N, Bj^klund M, Willman K et al. Nanobacteria: an infection cause for kidney stone formation. Kidney Int 1999; 56: 1893-1898
(check this in PDF content)
124
Hudelist G, Singer CF, Kubista E et al. Presence of nanobacteria in plasmmoma bodies of ovarian cancer: evidence for pathogenetic role in intratumoral biomineralization. Histopathology 2004; 45: 633-637
(check this in PDF content)
125
Khullar M, Sharma SK, Singh SK et al. Morphological and immunological characteristics of nanobacteria from human renal stones of a north Indian population. Urol Res 2004; 32: 190-195
(check this in PDF content)
126
Miller VM, Rodgers G, Charlesworth JA et al. Evidence of nanobacteria-like structures in calcified human arteries and cardiac valves. Am J Physiol Heart Circ Physiol 2004; 287: 1115­ 1124
(check this in PDF content)
127
Pusk6s LG, Tiszlavicz L, R6zga L et al. Detection of nanobacteria-like particles in human atherosclerotic plaques. Acta Biol Hung 2005; 56: 233-245
(check this in PDF content)
128
Shoskes DA, Thomas KD, Gomez E. Antinanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience. J Urol 2005; 173: 474-477
(check this in PDF content)
129
Wen Y, Li YG, Yang ZL et al. Detection of nanobacteria in serum, bile and gallbladder mucosa of patients with cholecystolithiasis. Chin Med J 2005; 118: 421-424
(check this in PDF content)
130
Ciftcioglu N, McKay DC, Mathew G et al. Nanobacteria: fact or fiction? Characteristics, detection, and medical importance of novel self-replicating, calcifying nanoparticles. J Invest Med 2006; 54: 385-394
(check this in PDF content)
131
Vali H, McKee MD, Мiftзioрlu N et al. Nanoforms: A new type protein-associated mineralization. Geoch Cosmoch Acta 2001; 65: 63-74
(check this in PDF content)
132
Benzerara K, Miller VM, Barell G et al. Search for microbial signatures within human and microbial calcifications using soft x-ray spectromicroscopy. J Invest Med 2006; 54: 367-379
(check this in PDF content)
133
Kumar V, Farell G, Yu S et al. Cell biology of pathologic renal calcification: contribution of crystal transcytosis, cell- mediated calcification, and nanoparticles. J Invest Med 2006; 54: 412-424
(check this in PDF content)
134
Shiekh FA, Khullar M, Singh SK. Lithogenesis: induction of renal calcifications by nanobacteria. Urol Res 2006; 34: 53-57
(check this in PDF content)
135
Еkerman KK, Kuikka JT, Мiftзioрlu N et al. Radiolabeling and in vivo distribution of nanobacteria in rabbit. Proc SPIE 1997; 3111: 436-442
(check this in PDF content)
136
GarcHa Cuerpo E, Kajander EO, Мiftзioрlu N et al. Nanobacteria; un modelo de neo-litogenesis experimental. Arch Esp Urol 2000; 53: 291-303
(check this in PDF content)
137
Shiekh FA, Khullar M, Singh SK. Lithogenesis: induction of renal calcification by nanobacteria. Urol Res 2003; 20: 1-5
(check this in PDF content)
138
Мiftзioрlu N, Vejdani K, Lee O et al. Association between Randall’s plaque and calcifying nanoparticles. Int J Nanomed 2008; 3 (1): 105-115
(check this in PDF content)
139
Cisar JO, Xu D-Q, Thompson J et al. An alternative interpretation of nanobacteria-induced biomineralization. PNAS 2000; 17: 11511-11515
(check this in PDF content)
140
Drancourt M, Jacomo V, Lйpidi H et al. Attempted isolation of Nanobacterium sp microorganisms from upper urinary tract stones. J Clin Microbiol 2003; 41: 368-372 Поступила в редакцию 05.10.2009 г. Принята в печать 23.11.2009 г.
(check this in PDF content)